Bluesight expands access to solutions through strategic partnership with Pharma Logistics. By Adam Rosenberg Health System Pharmacies Can Leverage Value Uncovered Through Reverse Distribution Services to Purchase Bluesight Solutions ALEXANDRIA, Va., April 22, 2026 - Bluesight, the leader in hospital intelligence solutions, formally announced a strategic partnership with Pharma Logistics, a leading provider of pharmaceutical reverse distribution services. This collaboration introduces an innovative financing model that allows healthcare systems to utilize their medication return credits to invest in Bluesight's full suite of technology solutions. As hospitals and health systems face escalating financial pressures, the partnership addresses the critical need for capital solutions. By leveraging the value recovered from unused and expired medications, pharmacy leaders now have an alternative means of acquiring technology that enhances patient safety and operational efficiency. Turning Recovered Value into Innovation Through this partnership, healthcare organizations that utilize Pharma Logistics for their pharmaceutical returns can apply their accrued credits directly toward the purchase of any Bluesight product, including: CostCheck, ControlCheck, KitCheck, ShortageCheck, 340BCheck, and PrivacyPro. "Our mission has always been to empower pharmacy teams with the tools they need to operate safely and efficiently," said Kevin MacDonald, CEO and Co-founder at Bluesight. "By partnering with Pharma Logistics, we are improving access to our critical technology. This enables health systems to turn what was once considered 'lost' value into a powerful engine for pharmacy innovation." Key Benefits of the Partnership: Through this collaboration, hospitals and health systems can: * Fund software acquisitions and expansions using existing reverse distribution credits rather than relying on new capital budget cycles. * Gain new flexibility in how they plan, prioritize, and deploy technology investments - whether they be core Bluesight technologies or additional product modules. * Quickly evaluate, adopt, and scale technologies that support improved operational efficiency, regulatory compliance, and financial performance. "Pharma Logistics is dedicated to providing full-service return solutions that simplify the lives of pharmacy staff," said David A. Hargraves, CEO at Pharma Logistics. "Our Credit Partner Program combines Pharma Logistics' value recovery efforts with Bluesight's industry-leading software solutions to help hospital pharmacies realize the vision of a tech-enabled future." Since late 2025, health systems across the country have begun adopting Bluesight solutions through this credit-based approach, deploying technology to enhance visibility, strengthen compliance, and improve medication management. About Bluesight Bluesight powers hospital operations with intelligence that simplifies inventory management, procurement, and compliance. Through its suite of industry-leading solutions, Bluesight ensures that health systems protect every patient and optimize every dollar. Over 3,000 United States and Canadian hospitals rely on Bluesight every day to have efficient and safe operations. For more information, please visit bluesight.com. About Pharma Logistics Pharma Logistics is a leader in pharmaceutical reverse distribution, helping healthcare organizations recover maximum value from unused and expired medications while ensuring regulatory compliance. Trusted by more than 12,000 hospitals, pharmacies, and government agencies nationwide, the company combines twice-patented technology, complete line-item visibility, and a dedicated collections team to maximize credit recovery and deliver consistent, measurable financial results. For more information, please visit www.pharmalogistics.com. Related resources. Bluesight expands access to solutions through strategic partnership... Health System Pharmacies Can Leverage Value Uncovered Through Reverse Distribution Services to Purchase Bluesight... How to reduce false positives in privacy monitoring without missing real risk over 305... Beyond the dashboard: how 3 systems are building... Becker's Spring Chief Pharmacy Officer Summit Recap Pharmacy procurement has never been more complex... A practical guide to NDC level contract compliance... Drugmakers raised list prices on more than 350 branded medications at the start of... How RFID supports a more efficient supply chain. Margins are tighter, drug shortages are more frequent, and medication waste from expirations continues... Previous slide Next slide

Bluesight has launched a redesigned 340BCheck platform to help healthcare organisations maintain compliance with the 340B drug pricing programme amid intensifying regulatory scrutiny. The platform builds on technology acquired from Sectyr in 2024 and features workflow-driven design alongside enhanced compliance capabilities. The launch comes as regulatory pressure intensifies. In fiscal year 2025, HRSA audited 115 covered entities, with nearly half receiving adverse findings and 75% showing incorrect OPAIS records. The platform offers full transaction auditing, database synchronisation, contract pharmacy management, and integrated documentation tools designed to maintain continuous audit readiness. Bluesight CEO Kevin MacDonald noted that covered entities must now manage significantly more regulatory complexity without additional staff. Over 3,000 US and Canadian hospitals currently use Bluesight solutions for hospital operations management.